Furthermore, Kaplan–Meier survival curves from CGGA dataset, demonstrated that patients with low- or high- grade gliomas, characterized by a low expression of PLCβ1, have a shorter survival time in both primary and recurrent gliomas compared to patients with high-PLCβ1 expression. The gene discussed is PLCB1; the disease is glioma.